Aisling Capital’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.78M | Sell |
44,581
-6,476
| -13% | -$258K | 3.93% | 3 |
|
|
2019
Q2 | $1.72M | Hold |
51,057
| – | – | 2.84% | 4 |
|
|
2019
Q1 | $2.71M | Hold |
51,057
| – | – | 4.07% | 4 |
|
|
2018
Q4 | $2.4M | Hold |
51,057
| – | – | 0.68% | 5 |
|
|
2018
Q3 | $4.49M | Hold |
51,057
| – | – | 0.97% | 6 |
|
|
2018
Q2 | $5.31M | Hold |
51,057
| – | – | 0.7% | 6 |
|
|
2018
Q1 | $4.09M | Hold |
51,057
| – | – | 0.73% | 6 |
|
|
2017
Q4 | $6.94M | Hold |
51,057
| – | – | 1.37% | 7 |
|
|
2017
Q3 | $8.27M | Hold |
51,057
| – | – | 1.36% | 8 |
|
|
2017
Q2 | $7.66M | Hold |
51,057
| – | – | 1.31% | 9 |
|
|
2017
Q1 | $7.97M | Hold |
51,057
| – | – | 1.45% | 12 |
|
|
2016
Q4 | $10.6M | Hold |
51,057
| – | – | 2.47% | 10 |
|
|
2016
Q3 | $11.7M | Hold |
51,057
| – | – | 2.41% | 13 |
|
|
2016
Q2 | $10.5M | Buy |
51,057
+84
| +0.2% | +$17.3K | 2.49% | 14 |
|
|
2016
Q1 | $12.9M | Hold |
50,973
| – | – | 2.59% | 14 |
|
|
2015
Q4 | $17.5M | Hold |
50,973
| – | – | 3.02% | 13 |
|
|
2015
Q3 | $13M | Buy |
+50,973
| New | +$13M | 2.28% | 16 |
|